Showing results (41-50 of 147) with videos related to
Sort By:
Pageof 15
Molecular Therapy. Methods & Clinical Development|June 4, 2016
Clinical development of gene therapy: results and lessons from recent successesSandeep Rp Kumar, David M Markusic, Moanaro Biswas, et al.The Journal of Clinical Investigation|April 2, 2004
Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VIIParis Margaritis, Valder R Arruda, Majed Aljamali, et al.Science (New York, N.Y.)|January 13, 2018
Gene therapy comes of ageCynthia E Dunbar, Katherine A High, J Keith Joung, et al.Plos One|March 25, 2016
Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned DogsMary Beth Callan, Mark E Haskins, Ping Wang, et al.Human Gene Therapy|December 4, 2010
Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal modelPatricia Favaro, Jonathan D Finn, Joshua I Siner, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2009
Enhanced factor VIII heavy chain for gene therapy of hemophilia ALingxia Chen, Hui Lu, Jinhui Wang, et al.Experimental Hematology|September 7, 2010
HIV-1 infection inhibits cytokine production in human thymic macrophagesTomasz Rozmyslowicz, Samuel L Murphy, Dareus O Conover, et al.Npj Drug Discovery|July 1, 2026
Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial functionSamuel L Murphy, Wai Hong Wilson Tang, Xiaolei Zhuang, et al.Journal of Virological Methods|June 9, 2005
Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymeraseGeorge Lin, Samuel L Murphy, Glen N Gaulton, et al.Journal of Virology|April 14, 2006
Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virusSamuel L Murphy, Maeran Chung-Landers, Marek Honczarenko, et al.Pageof 15